BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Arrow International, Inc. (ARRO) Announces Annual Meeting Voting Results


9/28/2007 10:13:41 AM

READING, Pa., Sept. 26 /PRNewswire-FirstCall/ -- Arrow International, Inc. announced today the final tabulation of votes at its Annual Meeting of Shareholders held on September 20, 2007.

-- Proposal 1 -- Shareholders voted to adopt the merger agreement with Teleflex Incorporated, with 99.8 percent of votes cast voting to approve the merger agreement. Approval of the merger agreement required a positive vote of a majority of shares voting on this proposal. The receipt of this shareholder vote satisfies the final condition necessary prior to closing the merger. -- Proposal 2 -- All of Arrow's director nominees were re-elected, with each receiving affirmative votes from in excess of 61.5 percent of votes cast. -- Proposal 3 -- Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent accounting firm with 99.8 percent of votes cast. -- Proposal 4 -- Shareholders defeated a proposed age limit for directors with 69.0 percent of the votes cast voting against the proposal.

As previously announced on July 23, 2007, Teleflex and Arrow entered into a definitive merger agreement, which was unanimously approved by both companies' Boards of Directors and provides for the payment to Arrow shareholders of $45.50 per share in cash without interest for each outstanding share of their Arrow common stock, representing a premium to shareholders of approximately 38.6% over the closing price of Arrow common stock on May 8, 2007, the last full trading day before the announcement of the Company's decision to explore strategic alternatives.

About Arrow

Arrow develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The company's products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists and other healthcare providers. Arrow's news releases and other company information can be found on the World Wide Web at http://www.arrowintl.com . Arrow's common stock trades on the NASDAQ Global Select Market(SM) under the symbol ARRO.

Arrow International, Inc.

CONTACT: Frederick J. Hirt, CFO of Arrow International, Inc.,+1-610-478-3117



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES